-
1دورية أكاديمية
المؤلفون: Pan H; School of Pharmaceutical Sciences.; Centre for Cellular & Structural Biology, Sun Yat-Sen University, Guangzhou, People's Republic of China., Liu J; School of Pharmaceutical Sciences.; Centre for Cellular & Structural Biology, Sun Yat-Sen University, Guangzhou, People's Republic of China., Deng W; School of Pharmaceutical Sciences.; Centre for Cellular & Structural Biology, Sun Yat-Sen University, Guangzhou, People's Republic of China., Xing J; School of Pharmaceutical Sciences.; Centre for Cellular & Structural Biology, Sun Yat-Sen University, Guangzhou, People's Republic of China., Li Q; School of Pharmaceutical Sciences.; Centre for Cellular & Structural Biology, Sun Yat-Sen University, Guangzhou, People's Republic of China., Wang Z; School of Pharmaceutical Sciences.; Centre for Cellular & Structural Biology, Sun Yat-Sen University, Guangzhou, People's Republic of China.
المصدر: International journal of nanomedicine [Int J Nanomedicine] 2018 May 29; Vol. 13, pp. 3189-3201. Date of Electronic Publication: 2018 May 29 (Print Publication: 2018).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101263847 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-2013 (Electronic) Linking ISSN: 11769114 NLM ISO Abbreviation: Int J Nanomedicine Subsets: MEDLINE
مواضيع طبية MeSH: Antibodies, Bispecific/*pharmacology , CD3 Complex/*immunology , Carcinoembryonic Antigen/*immunology , Immunotherapy/*methods , Polyethylene Glycols/*chemistry, Animals ; Antibodies, Bispecific/chemistry ; Antineoplastic Agents/immunology ; Antineoplastic Agents/pharmacology ; Half-Life ; Humans ; Immunoglobulin Fab Fragments/pharmacology ; Male ; Mice, SCID ; Neoplasms/therapy ; Rats, Sprague-Dawley ; Single-Domain Antibodies/pharmacology ; Xenograft Model Antitumor Assays
-
2دورية أكاديمية
المؤلفون: Deng W; School of Pharmaceutical Sciences.; Center for Cellular & Structural Biology, Sun Yat-Sen University, Guangzhou., Liu J; School of Pharmaceutical Sciences.; Center for Cellular & Structural Biology, Sun Yat-Sen University, Guangzhou., Pan H; School of Pharmaceutical Sciences.; Center for Cellular & Structural Biology, Sun Yat-Sen University, Guangzhou., Li L; School of Pharmaceutical Sciences.; Center for Cellular & Structural Biology, Sun Yat-Sen University, Guangzhou., Zhou C; School of Pharmaceutical Sciences.; Center for Cellular & Structural Biology, Sun Yat-Sen University, Guangzhou., Wang X; School of Pharmaceutical Sciences.; Center for Cellular & Structural Biology, Sun Yat-Sen University, Guangzhou., Shu R; Ying Rui Inc., Dong B; School of Biosciences and Biopharmaceutics, Guangdong Pharmaceutical University., Cao D; Department of Laboratory Medicine, Guangdong Second Provincial General Hospital, Guangzhou, Guangdong, China., Li Q; School of Pharmaceutical Sciences.; Center for Cellular & Structural Biology, Sun Yat-Sen University, Guangzhou., Wang Z; School of Pharmaceutical Sciences.; Center for Cellular & Structural Biology, Sun Yat-Sen University, Guangzhou.
المصدر: Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2018 Jan; Vol. 41 (1), pp. 1-8.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9706083 Publication Model: Print Cited Medium: Internet ISSN: 1537-4513 (Electronic) Linking ISSN: 15249557 NLM ISO Abbreviation: J Immunother Subsets: MEDLINE
مواضيع طبية MeSH: Antibodies, Bispecific/*genetics , Antibodies, Monoclonal, Humanized/*therapeutic use , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Breast Neoplasms/*therapy , Immunotherapy/*methods , Receptor, ErbB-2/*genetics, Animals ; Antibodies, Bispecific/therapeutic use ; Antibodies, Monoclonal, Humanized/genetics ; Antibody-Dependent Cell Cytotoxicity ; Breast Neoplasms/immunology ; Escherichia coli/genetics ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; MCF-7 Cells ; Mice ; Mice, SCID ; Molecular Targeted Therapy ; Neoplasm Metastasis ; Protein Engineering ; Receptor, ErbB-2/immunology ; Receptor, ErbB-2/metabolism ; Receptors, IgG/immunology ; Signal Transduction ; Single-Domain Antibodies/genetics ; Single-Domain Antibodies/therapeutic use ; Trastuzumab/therapeutic use ; Tumor Burden ; Xenograft Model Antitumor Assays
-
3دورية أكاديمية
المؤلفون: Liu, Jiayu, Jiang, Ying, Chen, Lingyan, Qian, Zhiwen, Zhang, YanAff1, Aff2, IDs12672023008367_cor5
المصدر: Discover Oncology. 15(1)
-
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
8دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
9دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
10دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.